Kuang Y

ORCID: 0000-0002-6830-0865 · 63 papers in corpus
other 2020
BMJ open ·doi:10.1136/bmjopen-2020-038153

INTRODUCTION: Women with polycystic ovary syndrome (PCOS) undergoing in vitro fertilization (IVF) protocols are typically characterised by an increased number of oocytes retrieved. The oocytes are often of poor quality, leading to lower pre…

observational 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.546232

OBJECTIVE: To evaluate whether endometrial thickness (EMT) change in response to progesterone has an effect on pregnancy outcomes in frozen-thawed embryo transfer (FET) cycles. DESIGN: Retrospective observational study. SETTING: Tertiary-…

observational 2020
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2020.01.010

RESEARCH QUESTION: Does preconception body mass index (BMI) affect neonatal outcomes in women with endometriosis who conceive with IVF? DESIGN: This retrospective study included 7086 women who delivered a singleton live birth through IVF b…

rct 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00129

Object: Is it possible to use different progestins cotreatment with human menopausal gonadotrophin (hMG) in women with advanced endometriosis but normal ovulation during controlled ovarian hyperstimulation (COH) in vitro fertilization (IVF)…

other 2020
Annals of translational medicine ·doi:10.21037/atm.2020.02.15

BACKGROUND: This study investigated the effects of medroxyprogesterone acetate (MPA) on the oocytes and embryos in patients with advanced endometriosis who had a normal ovarian reserve and tubal infertility and received controlled ovarian h…

observational 2020
Drug design, development and therapy ·doi:10.2147/dddt.s263138

PURPOSE: In patients who had advanced endometriosis, we use different protocols including GnRH agonist, GnRH antagonist and progestin-primed ovarian stimulation (PPOS) protocols to assess live-birth congenital malformations delivered after …

observational 2020
Frontiers in physiology ·doi:10.3389/fphys.2020.00415

BACKGROUND: Previous studies have reported the association between embryo quality and perinatal outcomes in fresh cycles, after cleavage-stage or blastocyst embryo transfer, and found no significant difference. However, in terms of vitrifie…

observational 2020
Annals of translational medicine ·doi:10.21037/atm-20-1459

BACKGROUND: Peak endometrial thickness (EMT), measured on the end of follicular phase or early luteal phase, is the most widely used marker for endometrial receptivity during infertility treatment. However, the clinical significance of foll…

observational 2020
Archives of gynecology and obstetrics ·doi:10.1007/s00404-020-05568-5

PURPOSE: To explore the trends of oocyte and pregnancy outcomes over the ovulation trigger-OPU (oocyte pickup) time interval in four mainly used COH protocols. METHODS: This retrospective study was conducted between January 2013 and July 2…

other 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.00391

Purpose: To screen out specific protein with different concentration in follicular fluid from advanced endometriosis and determine its direct effect on mouse oocytes matured in vitro. Methods: FF samples were obtained from 25 patients (EMS …

other 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00325

Background: The ability of anti-Müllerian hormone (AMH) to predict ovarian response has been studied extensively in gonadotropin-releasing hormone agonist and antagonist treatments, but no information is available regarding its value in pro…

observational 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00763

Background: Endometriosis is one of the most challenging diseases for doctors helping infertile women conceive, which has become a common method to help maternal endometriosis-associated infertility. Women with advanced endometriosis posses…

observational 2019
Frontiers in medicine ·doi:10.3389/fmed.2019.00316

The freeze-all strategy has been increasingly employed in the context of in vitro fertilization (IVF) cycles globally, but the relative advantages of this approach are not entirely understood. Herein we sought to assess how maternal age aff…

observational 2019
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2019.03.101

RESEARCH QUESTION: Does the use of a levonorgestrel-releasing intrauterine system (LNG-IUS) improve the ongoing pregnancy rate of vitrified-warmed embryo transfer in women with adenomyosis undergoing IVF? DESIGN: This retrospective study i…

observational 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00770

Background: Eutopic endometrium from women with endometriosis has functional changes in several aspects, which may largely account for the decrease in the quality of endometrial receptivity. It is of utmost importance to know whether freeze…

observational 2019
Drug design, development and therapy ·doi:10.2147/dddt.s210228

PURPOSE: Dydrogesterone (DYG) has been demonstrated to be an alternative progestin in the progestin-primed ovarian stimulation (PPOS) protocol with comparable oocyte retrieval and pregnancy outcomes. However, its safety regarding neonatal o…

observational 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00694

Background: To investigate the optimal ovulation trigger-oocyte pickup (OPU) interval of a progestin-primed ovarian stimulation (PPOS) protocol. Method: Patients with normal ovarian reserve in their first PPOS OPU cycle were enrolled in thi…

observational 2019
Drug design, development and therapy ·doi:10.2147/dddt.s212235

OBJECTIVE: Frozen-thawed embryo transfer enables surplus embryos derived from IVF or IVF-ICSI treatment to be stored and transferred in subsequent cycles into a more "physiologic environment". This study aimed to investigate the clinical ef…

observational 2019
Drug design, development and therapy ·doi:10.2147/dddt.s230129

PURPOSE: Dydrogesterone (DYG) is an alternative progestin in progestin-primed ovarian stimulation (PPOS) protocol with weaker pituitary suppression than medroxyprogesterone acetate (MPA) in normal ovulatory women. However, the endocrinologi…

rct 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00796

Objective: Progestin was recently used as an alternative of gonadotropin-releasing hormone (GnRH) analog for preventing premature luteinizing hormone (LH) surge with the aid of vitrification techniques, however, limited data were available …

observational 2019
Annals of translational medicine ·doi:10.21037/atm.2019.11.74

BACKGROUND: Non-elective freeze-all policy has been increasingly utilized in assisted reproductive treatment, but the optimal timing of frozen-thawed embryo transfer (FET) after controlled ovarian stimulation (COS) remains to be investigate…

review 2018
Pharmaceutical biology ·doi:10.1080/13880209.2018.1492620

CONTEXT: Scutellaria baicalensis Georgi (Lamiaceae) is a popular medicinal plant. Its roots are used as the famous traditional Chinese medicine Huang-Qin, which is recorded in Chinese Pharmacopoeia, European Pharmacopoeia, and British Pharm…

other 2018
Journal of ovarian research ·doi:10.1186/s13048-018-0469-x

BACKGROUND: Premature ovulation occurs at a high rate in natural-cycle in vitro fertilization (IVF), and cycle cancellation further hampers the overall efficiency of the procedure. While lower levels of estradiol (E2) are observed in preovu…

rct 2018
Trials ·doi:10.1186/s13063-018-2850-x

BACKGROUND: Progress in vitrification techniques has allowed reproductive physicians to consider new strategies for using progestin as an alternative to a GnRH analogue to improve in vitro fertilisation (IVF). However, the role of progestin…

rct 2018
Medical science monitor : international medical journal of experimental and clinical research ·doi:10.12659/msm.906602

BACKGROUND Increasing the success rate of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) is a duty of clinicians that has made many seek a variety of protocols. This study was undertaken to use a liquid chromatography-ma…